⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
NBTX News
Nanobiotix S.A. American Depositary Shares
NANOBIOTIX annonce les modalites definitives de son offre globale sursouscrite a hauteur de 85 millions d’euros
globenewswire.com
NBTX
Nanobiotix Announces Pricing of Oversubscribed €85m Global Offering
globenewswire.com
NBTX
Nanobiotix Announces Pricing of Oversubscribed €85m Global Offering
globenewswire.com
NBTX
Nanobiotix Announces Trading Resumption of Its Ordinary Shares on Euronext Paris
globenewswire.com
NBTX
Nanobiotix Announces Temporary Trading Halt of Its Ordinary Shares on Euronext Paris
globenewswire.com
NBTX
Nanobiotix Announces Launch of Global Follow-On Offering
globenewswire.com
NBTX
Nanobiotix Announces Launch of Global Follow-On Offering
globenewswire.com
NBTX
Nanobiotix Announces Presentation of Part 1 Data From a Randomized Phase 2 Clinical Trial Evaluating JNJ-1900 (NBTXR3) in Stage 3 Inoperable Lung Cancer
globenewswire.com
NBTX
Nanobiotix Announces Protocol Amendment to Ongoing Global Phase 3 Head and Neck Cancer Study
globenewswire.com
NBTX
Nanobiotix Announces New Preclinical Data Supporting Improved Systemic Bioavailability and Reduced Toxicity for LNP-Delivered DNA Immunotherapy After Pre-Treatment With Nanoprimer Technology
globenewswire.com
NBTX